Core Viewpoint - The EU Chamber of Commerce in China strongly opposes the EU's restrictions on Chinese companies participating in public procurement for medical devices, expressing serious concerns about the impact of this market distortion on China-EU investment relations [1][2]. Group 1 - The EU Commission, on June 20, excluded Chinese companies from participating in EU public procurement projects for medical devices valued over 5 million euros, requiring that products and components from China not exceed 50% [1]. - The EU Chamber criticizes the EU's unilateral protectionist measures and the discriminatory practices against Chinese companies, stating that the conclusions of the EU's investigation under the "International Procurement Instrument" are not fair [1]. - The statement emphasizes that the EU's actions represent blatant discrimination against Chinese enterprises and products, raising serious concerns about the impact on China-EU medical device trade and investment relations [1]. Group 2 - The EU Chamber calls for the EU to immediately cease its erroneous practices and provide a fair, just, and non-discriminatory business environment for Chinese medical device companies [2].
欧盟中国商会声明:坚决反对!
券商中国·2025-06-21 04:45